Jordan Zad News –
The American New York Times said that US President Donald Trump is using the drug Dexamethasone in the treatment of Corona disease, in which his infection was announced Thursday night, Friday.
Dexamethasone is a corticosteroids that are similar to the natural hormone produced by the adrenal glands in the body, and it is often used to replace this chemical when the body does not produce enough of it, according to the National Library of Medicine in the United States.
According to the Hikma Pharmaceutical Company website, the company produces Dexamethasone in the US market.
Al-Hikma is a multinational company established in 1978 in Jordan by the Jordanian Samih Darwaza, and it is the first company of Arab origin to enter the American, British and European market.
Then it expanded and acquired factories in America, Portugal, Italy, Tunisia, Saudi Arabia, Egypt and Algeria, and reached about 52 markets in the world.
It was first listed on the London Stock Exchange as an international joint stock company in 2005, as was the Dubai Stock Exchange.
The original medicines are manufactured with excellence by international companies and others with or without branding, and the headquarters for their management is today in London.
It has many manufacturing sites in more than one Arab and foreign country. The company is committed to applying high quality standards or so-called good manufacturing practices GMP.
These were the details of the news Trump uses treatment produced by a Jordanian company | Jordanian... for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at saudi24news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.